While the U.S. waits on funding and for the U.S. Food and Drug Administration (FDA) to decide on which virus strain to attack through boosters, Moderna and other vaccine companies are anticipating waning immunity to become a concern.
"This virus is not getting less infectious," Moderna CEO Stéphane Bancel told Yahoo Finance. "As you see more and more infectious variants ... We are not done with this virus mutating," he said.
The biggest risk in the fall, if boosting is delayed, is the potential for hospitals to fill up with those that are the most vulnerable all over again, Bancel said.
The increased circulation from the intersection of waning immunity and a more transmissible variant, as is being observed with more Omicron subvariants in the U.S. and abroad, is the real risk, he said.
"We have a risk in the fall — if we don't have the booster campaign early enough —that we might not be in a great spot in the fall," Bancel said.
WASHINGTON (AP) — For the first time, the U.S. came close to providing health care for all during the coronavirus pandemic — but for just one condition, COVID-19.
As COVID-19 testing continues to recede in Florida, it is far behind other states in tracking the virus with promising technology that relies on wastewater.
New Hampshire health officials said Tuesday that the state is now averaging 434 reported new cases per day, the highest rate since Feb. 15. The rate of new cases has risen 231% since April 2.
There are 3,128 known active cases of COVID-19 in the state, the most since Feb. 16.
The U.S. on Wednesday surpassed 1 million Covid-19 deaths, according to data compiled by NBC News — a once unthinkable scale of loss even for the country with the world's highest recorded toll from the virus.
Recent Comments